Butanedione

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	Acetamide SCHEMBL29032534	0.87	—	—
	Butanedione SCHEMBL10788198	0.85	TSHR (0.50)	TSHRTHPOLMNABLMPMP22
	SCHEMBL931791	0.83	—	—
	Acetone SCHEMBL28842497	0.83	—	—
	Acetic Acid SCHEMBL7894019	0.83	—	—
	Butanedione SCHEMBL1696461	0.82	TSHR (0.70)	TSHRTHPOLMNABLMPMP22
	Butanedione SCHEMBL28134897	0.82	LMNA (0.80)	TSHRTHPOLMNABLMPMP22
	Butanedione SCHEMBL1457594	0.79	ALDH1A1 (0.62)	TSHRTHPOLMNABLMPMP22
	Butanedione SCHEMBL28136465	0.78	TSHR (0.64)	TSHRTHPOLMNABLMPMP22
	Thioacetamide SCHEMBL28155309	0.78	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.